New data from OASIS 4 on oral semaglutide 25 mg to reveal insights on cardiometabolic health among adults with obesity or overweight Additional trial insights ...

GLP-1 drugs like Ozempic and Wegovy are transforming public health and consumer habits. Here we explore their explosive ...

The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...

Medically, you don’t have to taper off semaglutide, but many experts recommend it when stopping the medication. Some ...

GLP-1 initiation was common among patients who underwent bariatric surgery, especially sleeve gastrectomy vs Roux-en-Y gastric bypass.

Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

Chemistry researchers at the University of Utah have uncovered an enzyme, dubbed PapB, that can "tie off" therapeutic ...

Henry Meds is a subscription-based telehealth platform that focuses on treatment for endocrine-related conditions. Offerings ...

Clinical studies demonstrate that consistent GLP-1 therapy can result in 10–20% body weight reduction, alongside improved ...

A woman's abdominal discomfort turned out to be caused by a build up of food in her stomach. And the treatment involved diet soda.

Eli Lilly and Company's strong Phase 3 diabetes drug results boost its GLP-1 franchise. Click for my updated look at LLY ...